Mutual of America Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Mutual of America Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-160	Closed	-$29K	–	1698
2018 Q4	$29K	Buy	160 +40	+33%	+$8.72K	﹤0.01%	1371
2018 Q3	$38K	Hold	120	–	–	﹤0.01%	1304
2018 Q2	$48K	Sell	120 -40	-25%	-$17.5K	﹤0.01%	1207
2018 Q1	$57K	Buy	160 +20	+14%	+$7.43K	﹤0.01%	1179
2017 Q4	$55K	Hold	140	–	–	﹤0.01%	1182
2017 Q3	$60K	Buy	140 +40	+40%	+$10.7K	﹤0.01%	1185
2017 Q2	$16K	Buy	+100	New	+$13.6K	﹤0.01%	1208

Other funds holding ABEO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Mutual of America Capital Management's ABEO Position: Q1 2019 in Review

Mutual of America Capital Management sold out of Abeona Therapeutics (ABEO) in Q1 2019, closing a stake of 160 shares — an estimated $29K sold.

Mutual of America Capital Management first reported a position in ABEO in Q2 2017 and held it in 7 quarters. The position peaked at $60K in Q3 2017. 87 funds tracked by Wall St. Rank hold ABEO as of Q1 2019.

Mutual of America Capital Management reported no remaining Abeona Therapeutics position as of Q1 2019 after selling out during the quarter.
Mutual of America Capital Management sold 160 Abeona Therapeutics shares in Q1 2019, an estimated $29K.
Mutual of America Capital Management first reported a position in Abeona Therapeutics in Q2 2017 and held it in 7 quarters.
Mutual of America Capital Management's Abeona Therapeutics position peaked at $60K in Q3 2017.
87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2019.

Based on Mutual of America Capital Management's 13F filing for Q1 2019, filed 13 May 2019.